PharmEvo comes onboard with NUST for educational equity

NUST & PharmEvo Private Limited signed a Memorandum of Agreement (MoA) on January 11, 2022, for providing educational equity at NUST.

NUST’s endowment size currently stands at 192 seats which NUST plans to take to 400 in the near future.

It is with the help and generosity of the community leaders such as Mr Haroon Qassim, MD PharmEvo, that NUST is encouraged to aim for greater feats of achievement. Such partners are our ambassadors who believe in our cause of making NUST a need-blind Centre of Excellence.

Industry leaders, partners and individuals are welcome to work with NUST as champions of impact actively working to build the nation through transformative higher education.